C57BL/6JCya-Eif2ak2em1flox/Cya
Common Name
Eif2ak2-flox
Product ID
S-CKO-04447
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-19106-Eif2ak2-B6J-VA
When using this mouse strain in a publication, please cite “Eif2ak2-flox Mouse (Catalog S-CKO-04447) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Eif2ak2-flox
Strain ID
CKOCMP-19106-Eif2ak2-B6J-VA
Gene Name
Product ID
S-CKO-04447
Gene Alias
Pkr, Tik, Prkr, 2310047A08Rik, 4732414G15Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 17
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000024884
NCBI RefSeq
NM_011163
Target Region
Exon 5~7
Size of Effective Region
~2.1 kb
Overview of Gene Research
Eif2ak2, also known as protein kinase R (PKR), encodes a kinase that phosphorylates eukaryotic translation initiation factor 2 alpha (eIF2α), orchestrating the cellular stress response [4]. It is involved in multiple pathways such as endoplasmic reticulum stress response and is associated with various biological processes like immune response and inflammation [3]. Genetic models, like gene knockout mouse models, can be valuable for studying its functions.
In Eif2ak2 gene knockdown mice, the inhibitory effect of berberine on the secretion of inflammatory cytokines (IL-1β, IL-6, IL-18 and TNF-α) was attenuated, highlighting an Eif2ak2-dependent anti-inflammatory efficacy [1]. In septic AKI models, Eif2ak2 could directly target absent in melanoma 2 (AIM2), positively regulating its expression and promoting PANoptosis, a type of inflammatory programmed cell death [2]. Pharmacological and genetic inhibition of Eif2ak2 attenuated NLRP3 and AIM2 inflammasomes activation in macrophages, suppressing the release of cytokines like IL-1β and IL-18 in sepsis-related studies [5].
In conclusion, Eif2ak2 plays a crucial role in the cellular stress response, inflammation, and sepsis-associated cell death processes. Gene knockdown mouse models have been instrumental in revealing its role in anti-inflammatory effects and sepsis-induced acute kidney injury, providing insights into the underlying mechanisms of these disease-related processes [1,2,5].
References:
1. Wei, Wei, Zeng, Qingxuan, Wang, Yan, Jiang, Jiandong, Song, Danqing. 2022. Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. In Acta pharmaceutica Sinica. B, 13, 2138-2151. doi:10.1016/j.apsb.2022.12.009. https://pubmed.ncbi.nlm.nih.gov/37250154/
2. Wei, Siwei, Wu, Lei, Xiang, Zhen, Jiang, Liubing, Du, Zhen. 2024. EIF2AK2 protein targeted activation of AIM2-mediated PANoptosis promotes sepsis-induced acute kidney injury. In Renal failure, 46, 2403649. doi:10.1080/0886022X.2024.2403649. https://pubmed.ncbi.nlm.nih.gov/39311631/
3. Thomsen, Mirja, Lange, Lara M, Zech, Michael, Lohmann, Katja. 2023. Genetics and Pathogenesis of Dystonia. In Annual review of pathology, 19, 99-131. doi:10.1146/annurev-pathmechdis-051122-110756. https://pubmed.ncbi.nlm.nih.gov/37738511/
4. Kuipers, Demy J S, Mandemakers, Wim, Lu, Chin-Song, Bertoli-Avella, Aida M, Bonifati, Vincenzo. 2020. EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia. In Annals of neurology, 89, 485-497. doi:10.1002/ana.25973. https://pubmed.ncbi.nlm.nih.gov/33236446/
5. Xie, Min, Yu, Yan, Kang, Rui, Jiang, Jianxin, Tang, Daolin. 2016. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. In Nature communications, 7, 13280. doi:10.1038/ncomms13280. https://pubmed.ncbi.nlm.nih.gov/27779186/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
